Arcturus Therapeutics Ltd. Pre-Tax Income
Arcturus Therapeutics Ltd. reported Pre-Tax Income of -$21.79 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-18.
Discontinued › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest · last filed 2019-03-18
- Arcturus Therapeutics Ltd. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2018 was -$21.79M.
- Arcturus Therapeutics Ltd. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2017 was -$10.90M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 12 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 12 month as first filed |
|---|---|---|
| 2018-12-31 | -$21.79M 10-K · filed 2019-03-18 | |
| 2017-12-31 | -$10.90M 10-K · filed 2019-03-18 | |
| 2016-12-31 | -$1.54M 20-F · filed 2018-05-14 | -$24.53M 20-F · filed 2017-04-28 |
| 2015-12-31 | -$1.90M 20-F · filed 2018-05-14 | -$19.40M 20-F · filed 2016-03-04 |
| 2014-12-31 | -$32.85M 20-F · filed 2017-04-28 | |
| 2013-12-31 | -$10.49M 20-F · filed 2016-03-04 |